Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 18:5:F1000 Faculty Rev-370.
doi: 10.12688/f1000research.7605.1. eCollection 2016.

Epileptogenesis in neurocutaneous disorders with focus in Sturge Weber syndrome

Anna Pinto  1 , Mustafa Sahin  2 , Phillip L Pearl  3
Affiliations
Review

Epileptogenesis in neurocutaneous disorders with focus in Sturge Weber syndrome

Anna Pinto et al. F1000Res. .

Abstract

Epilepsy is a major morbidity in Sturge Weber syndrome, a segmental vascular neurocutaneous disorder classically associated with facial angiomas, glaucoma, and leptomeningeal capillary-venous type vascular malformations. The extent of the latter correlates with neurological outcome. Post-zygotic mosaicism for the activating mutation p.R183Q of the GNAQ gene has been identified as the major cause. GNAQ encodes for an alpha subunit of a heterotrimeric G protein critical to blood vessel development. The earlier the timing of the mutation in development, the more severe the involvement, e.g. from isolated port-wine stains to the full syndrome. The strongest predictors of adverse outcomes are MRI and the presence of angiomas involving any part of the forehead, delineated inferiorly from the outer canthus of the eye to the top of the ear, and including the upper eyelid. The neurological course may be progressive and the typical constellation of symptoms is focal onset seizures, hemiparesis, headache, stroke-like episodes, behavior problems, intellectual disability, and visual field deficits. Antiseizure medications are effective in about half of patients. The presence of localized seizures, focal neurological deficits, and drug resistant epilepsy indicate epilepsy surgical evaluation. Earlier seizure onset, i.e. before six months of age, is associated with a more severe course with significant residual deficits. Factors contributing to epileptogenesis include decreased brain tissue perfusion due to abnormal venous drainage, anoxic injury contributing to cerebral calcification, breakdown of the blood-brain barrier, and the presence of developmental cortical malformations. Pre-symptomatic prophylactic treatment may be a future option to modify the course of the disease including the associated epileptogenesis.

Keywords: Sturge Weber syndrome; epilepsy; epileptogenesis; neurocutaneous syndromes; seizures.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare that they have no competing interests.

No competing interests were disclosed.

Figures

Figure 1.
Figure 1.. Schematic representation of GNAQ (encodes for Gαq) signaling via RAS/ERK pathway.
See this image and copyright information in PMC

References

    1. Shirley MD, Tang H, Gallione CJ, et al. : Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013;368(21):1971–1979. 10.1056/NEJMoa1213507 - DOI - PMC - PubMed

    2. F1000 Recommendation

    1. Lo W, Marchuk DA, Ball KL, et al. : Updates and future horizons on the understanding, diagnosis, and treatment of Sturge-Weber syndrome brain involvement. Dev Med Child Neurol. 2012;54(3):214–223. 10.1111/j.1469-8749.2011.04169.x - DOI - PMC - PubMed
    1. Kimple AJ, Bosch DE, Giguère PM, et al. : Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets. Pharmacol Rev. 2011;63(3):728–749. 10.1124/pr.110.003038 - DOI - PMC - PubMed
    1. Nakashima M, Miyajima M, Sugano H, et al. : The somatic GNAQ mutation c.548G>A (p.R183Q) is consistently found in Sturge-Weber syndrome. J Hum Genet. 2014;59(12):691–693. 10.1038/jhg.2014.95 - DOI - PubMed
    1. Mizuno N, Itoh H: Functions and regulatory mechanisms of Gq-signaling pathways. Neurosignals. 2009;17(1):42–54. 10.1159/000186689 - DOI - PubMed

LinkOut - more resources